Elevated pre-AHSCT absolute total CD19⁺B-cell count is significantly associated with improved PFS and OS. For all patients pre-AHSCT, patients with absolute total CD19⁺ B-cell counts in the highest quartile had improved PFS (P = .01) and OS (P = .0003) compared those in the middle and lowest quartiles.